Importer of Controlled Substances Registration, 836 [2018-00118]
Download as PDF
<![CDATA[
836
Federal Register / Vol. 83, No. 5 / Monday, January 8, 2018 / Notices
the ’803 trademark; and whether an
industry in the United States exists or
is in the process of being established as
required by subsection (a)(2) of section
337;
(2) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
Alfay Designs, Inc., 665 Martin Street,
Rahway, NJ 07065.
Mighty Mug, Inc., 665 Martin Street,
Rahway, NJ 07065.
Harry Zimmerman, 310 Comstock
Avenue, Los Angeles, CA 90024.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the amended complaint is to be
served:
Telebrands, Corp., One Telebrands
Plaza, Fairfield, NJ 07004.
HIRALIY, Room 1306, Easter Tower,
Poly World Trade Center Pazhou, No.
1000 Xingang Dong Road, Haizhu
District, Guangzhou, Guangdong
Province, China.
Chekue, Shenzhen Chekue Trading Co.
Ltd., Shenzhen, Guangdong Province,
518131 China.
Tapcet, Guangzhou Tinghui Trade Co.,
Ltd., Guangzhou, Tianhe, Longdong
W Street, Guangdong Province, China.
OUOH, Zhejiang OUOH Houseware Co.,
Ltd., No. 1278–1308 Wanxiang Road,
Wanquan Town, Wenzhou, Zhejiang
Province, 325204 China.
DevBattles, 3rd Floor, Street Cardinala
Josepha Slipogo, 7, Ternopil, Ukraine,
46000.
OTELAS, MB, Panevezio g.7–19, LT–
92316, Klaipeda, Lithuania.
Artiart Limited, 8F–4, No. 412, SEC5,
Chung Hsiao East Road, Taipei,
Taiwan.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(3) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the amended complaint
and the notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the amended complaint
and the notice of investigation.
Extensions of time for submitting
responses to the amended complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
amended complaint and in this notice
may be deemed to constitute a waiver of
the right to appear and contest the
allegations of the amended complaint
and this notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the amended complaint and
this notice and to enter an initial
determination and a final determination
containing such findings, and may
result in the issuance of an exclusion
order or a cease and desist order or both
directed against the respondent.
By order of the Commission.
Issued: January 3, 2018.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2018–00104 Filed 1–5–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration as importers of various
classes of schedule I or II controlled
substances.
SUMMARY:
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
FR Docket
Published
Galephar Pharmaceutical Research, Inc .........................................................................................................
Rhodes Technologies ......................................................................................................................................
Anderson Brecon, Inc ......................................................................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
Company
82 FR 49663
82 FR 51298
82 FR 52941
October 26, 2017.
November 3, 2017.
November 15, 2017.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
VerDate Sep<11>2014
16:29 Jan 05, 2018
Jkt 244001
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: December 29, 2017.
Neil D. Doherty,
Deputy Assistant Administrator.
[FR Doc. 2018–00118 Filed 1–5–18; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
NATIONAL SCIENCE FOUNDATION
Proposal Review Panel for Ocean
Sciences; Notice of Meeting
In accordance with the Federal
Advisory Committee Act (Pub. L. 92–
463, as amended), the National Science
Foundation (NSF) announces the
following meeting:
Name and Committee Code: Proposal
Review Panel for Ocean Sciences
(#10752)—C–DEBI, University of
Southern California (Site Visit).
Date And Time:
January 29, 2018; 8:00 a.m.–9:00 p.m.
January 30, 2018; 8:00 a.m.–4:00 p.m.
Place: C–DEBI, University of Southern
California, Los Angeles, CA 90089.
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 83, Number 5 (Monday, January 8, 2018)]
[Notices]
[Page 836]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00118]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration as importers of
various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Galephar Pharmaceutical 82 FR 49663 October 26, 2017.
Research, Inc.
Rhodes Technologies......... 82 FR 51298 November 3, 2017.
Anderson Brecon, Inc........ 82 FR 52941 November 15, 2017.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrants to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed persons.
Dated: December 29, 2017.
Neil D. Doherty,
Deputy Assistant Administrator.
[FR Doc. 2018-00118 Filed 1-5-18; 8:45 am]
BILLING CODE 4410-09-P
